-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RLBUCNST4ohnFcvnUXhMyu9bqCy//UfThBdZRnxGd1e2+mJPWL++Mlw4iRR4n7zR bKFrQhtwm0IwrijqQ2PoEA== 0000909012-10-000481.txt : 20100927 0000909012-10-000481.hdr.sgml : 20100927 20100927171217 ACCESSION NUMBER: 0000909012-10-000481 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100927 DATE AS OF CHANGE: 20100927 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PENWEST PHARMACEUTICALS CO CENTRAL INDEX KEY: 0001047188 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911513032 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-55303 FILM NUMBER: 101091482 BUSINESS ADDRESS: STREET 1: 2981 ROUTE 22 STREET 2: SUITE 2 CITY: PATTERSON STATE: NY ZIP: 12563-2335 BUSINESS PHONE: 877-736-9378 MAIL ADDRESS: STREET 1: 2981 ROUTE 22 STREET 2: SUITE 2 CITY: PATTERSON STATE: NY ZIP: 12563-2335 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PERCEPTIVE ADVISORS LLC CENTRAL INDEX KEY: 0001224962 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 499 PARK AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-205-5340 MAIL ADDRESS: STREET 1: 499 PARK AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 SC 13D/A 1 t305056.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (AMENDMENT NO. 16) (RULE 13D-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). PENWEST PHARMACEUTICALS CO. - -------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 - -------------------------------------------------------------------------------- (TITLE OF CLASS OF SECURITIES) 709754105 - -------------------------------------------------------------------------------- (CUSIP NUMBER) JOSEPH EDELMAN, 499 PARK AVENUE, 25TH FLOOR, NEW YORK, NY 10022, (646) 205-5300 - -------------------------------------------------------------------------------- (NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO RECEIVE NOTICE AND COMMUNICATIONS) SEPTEMBER 20, 2010 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D/A, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. [ ] Note: Schedules filed in paper format shall include a signed original and five copies of the Schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. - -------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 709754105 13D/A Page 2 of 5 Pages - --------- ---------------------------------------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) PERCEPTIVE ADVISORS LLC - --------- ---------------------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A GROUP* (a)[X] (b) - --------- ---------------------------------------------------------------------------------------------- 3. SEC USE ONLY - --------- ---------------------------------------------------------------------------------------------- 4. SOURCES OF FUNDS OO (Funds from Investment Advisory Clients). - --------- ---------------------------------------------------------------------------------------------- 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) - --------- ---------------------------------------------------------------------------------------------- 6. CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - ------------------- ---- ------------------------------------------------------------------------------- NUMBER OF SHARES 7. SOLE VOTING POWER ---- ------------------------------------------------------------------------------- BENEFICIALLY OWNED BY 8. SHARED VOTING POWER 0 ---- ------------------------------------------------------------------------------- EACH REPORTING 9. SOLE DISPOSITIVE POWER ---- ------------------------------------------------------------------------------- PERSON WITH 10. SHARED DISPOSITIVE POWER 0 ---- ------------------------------------------------------------------------------- - --------- ---------------------------------------------------------------------------------------------- 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - -------------------------------------------------------------------------------------------------------- 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES * - -------------------------------------------------------------------------------------------------------- 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11 0% - --------- ---------------------------------------------------------------------------------------------- 14. TYPE OF REPORTING PERSON* IA - --------- ---------------------------------------------------------------------------------------------- 13D/A Page 3 of 5 Pages CUSIP No. 709754105 - --------- ---------------------------------------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) JOSEPH EDELMAN - --------- ---------------------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A GROUP* (a)[X] (b) - --------- ---------------------------------------------------------------------------------------------- 3. SEC USE ONLY - --------- ---------------------------------------------------------------------------------------------- 4. SOURCES OF FUNDS OO - --------- ---------------------------------------------------------------------------------------------- 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) - --------- ---------------------------------------------------------------------------------------------- 6. CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES OF AMERICA - --------- ---------------------------------------------------------------------------------------------- - ------------------- ---- ------------------------------------------------------------------------------- NUMBER OF SHARES 7. SOLE VOTING POWER 0 ---- ------------------------------------------------------------------------------- BENEFICIALLY OWNED BY 8. SHARED VOTING POWER 0 ---- ------------------------------------------------------------------------------- EACH REPORTING 9. SOLE DISPOSITIVE POWER 0 ---- ------------------------------------------------------------------------------- PERSON WITH 10. SHARED DISPOSITIVE POWER 0 ---- ------------------------------------------------------------------------------- - --------- ---------------------------------------------------------------------------------------------- 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - -------------------------------------------------------------------------------------------------------- 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES * - -------------------------------------------------------------------------------------------------------- 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11 0% - --------- ---------------------------------------------------------------------------------------------- 14. TYPE OF REPORTING PERSON* IN - --------- ----------------------------------------------------------------------------------------------
13D/A Page 4 of 5 Pages CUSIP No. 709754105 EXPLANATORY NOTE: This Amendment No. 16 relates to and amends the Statement of Beneficial Ownership on Schedule 13D of Perceptive Advisors LLC, a Delaware limited liability company (the "Investment Manager") and Joseph Edelman, the managing member of the Investment Manager (each, a Reporting Person and, collectively, the "Reporting Persons"), initially filed jointly by the Reporting Persons with the Securities and Exchange Commission on July 17, 2008 and amended on July 18, 2008, October 23, 2008, November 21, 2008, December 19, 2008, January 12, 2009, March 3, 2009, March 12, 2009, March 30, 2009, April 28, 2009, June 22, 2009, February 5, 2010, May 28, 2010, July 1, 2010, August 9, 2010 and August 20, 2010 (as so amended, the "Statement"), with respect to the common stock, par value $0.001 (the "Common Stock") of Penwest Pharmaceuticals Co., a Washington corporation (the "Issuer"). Items 4 and 5 of the Statement are hereby amended to the extent hereinafter expressly set forth. All capitalized terms used and not expressly defined herein have the respective meanings ascribed to such terms in the Statement. ITEM 4. PURPOSE OF TRANSACTION Item 4 of the Statement is hereby amended to add the following: On September 20, 2010, the Merger Sub accepted the tender of all of the shares of Common Stock held by the Reporting Persons, pursuant to the terms of the Offer and the Merger was completed. The Reporting Persons received the consideration for such tender from Merger Sub on September 23, 2010 and September 24, 2010. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER Item 5 of the Statement is hereby amended and restated as follows: Reference is made to Item 4 of the Statement. As of September 20, 2010 the Reporting Persons ceased to be the beneficial owner of any securities of the Issuer. 13D/A Page 5 of 5 Pages CUSIP No. 709754105 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. September 27, 2010 ------------------ Date PERCEPTIVE ADVISORS LLC /s/ Joseph Edelman ------------------ Signature Joseph Edelman/Managing Member ------------------------------ Name/Title September 27, 2010 ------------------ Date /s/ Joseph Edelman ------------------ Signature Joseph Edelman -------------- Name/Title The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7 for other parties for whom copies are to be sent. -----END PRIVACY-ENHANCED MESSAGE-----